NCT02009007

Brief Summary

Liberal fluid administration is one of risk factors of developing acute lung injury (ALI) in thoracic surgery. Therefore, the investigators try to restrain fluid administration, and in the case of intraoperative hypotension, the investigators often administer vasoactive agents or inotropes. One lung ventilation (OLV) which is routinely employed for thoracic surgery decrease arterial oxygenation and oxygen delivery to brain can be also decreased. In this study, the investigators compared dopamine and phenylephrine in respect to maintaining cerebral oxygen saturation in major thoracic surgery. The investigators hypothesis is that dopamine is better than phenylephrine to maintain cerebral oxygen saturation in thoracic surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Dec 2012

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2013

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 11, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

December 11, 2013

Status Verified

December 1, 2013

Enrollment Period

1.5 years

First QC Date

November 13, 2013

Last Update Submit

December 6, 2013

Conditions

Keywords

cerebral oximeterone lung ventilationdopaminephenylephrine

Outcome Measures

Primary Outcomes (1)

  • Cerebral oximeter reading

    at 60 minutes after one lung ventilation

Secondary Outcomes (3)

  • cardiac output

    at 60 minutes after one lung ventilation

  • incidence of delirium

    participants will be followed for the first 48 hours of ICU stay

  • incidence of acute renal injury

    participants will be followed for the first 48 hours of ICU stay

Study Arms (2)

dopamine

EXPERIMENTAL

dopamine is administered to maintain systolic blood pressure in the range of 80-120% of baseline during operation

Drug: dopamine

phenylephrine

EXPERIMENTAL

Phenylephrine is administered to maintain systolic blood pressure in the range of 80-120% of baseline during operation

Drug: phenylephrine

Interventions

continuous infusion during operation

dopamine

continuous infusion of phenylephrine during operation

phenylephrine

Eligibility Criteria

Age65 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Elective surgery
  • American society of anesthesia physical status I-III

You may not qualify if:

  • Symptomatic cardiovascular disease
  • Poorly controlled hypertension (systolic arterial pressure ≥160 mm Hg)
  • Cerebrovascular disease
  • Poorly controlled diabetes mellitus (blood glucose ≥200 mg/dl)
  • Diuretics or antidepressant use before operation
  • Renal insufficiency (creatinine\>1.5 mg/dl)
  • Cerebral infarction
  • Documented coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung medical center

Seoul, 135-710, South Korea

RECRUITING

MeSH Terms

Conditions

HypoxiaHypotension

Interventions

DopaminePhenylephrine

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Biogenic MonoaminesBiogenic AminesAminesOrganic ChemicalsCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsEthanolaminesAmino AlcoholsAlcohols

Study Officials

  • Hyun Joo Ahn

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 13, 2013

First Posted

December 11, 2013

Study Start

December 1, 2012

Primary Completion

June 1, 2014

Study Completion

December 1, 2014

Last Updated

December 11, 2013

Record last verified: 2013-12

Locations